COSCIENS Biopharma (CSCI) Accounts Payable

Annual Accounts Payable

$1.87 M
-$172.00 K-8.44%

December 1, 2023

Summary

Performance

1-Year Change

-8.44%

3-Year Change

+57.2%

5-Year Change

+45.55%

15-Year Change

+52.7%

CSCI Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

30.84%
CSCI annual accounts payable is higher than 30.84% of companies in Healthcare sector

High & Low

All-time High

$41.80 M
CSCI annual accounts payable is currently -95.54% below its historical high of $41.80 million

3-Year Low

$934.00 K
CSCI annual accounts payable is currently +99.79% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
CSCI previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
CSCI next annual earnings announcement has not yet been scheduled

OtherCSCIbalance sheetmetrics:

Annual Accounts Receivable

$126.10 K
CSCI annual accounts receivable is $126.10 thousand

Annual Total Liabilities

$2.71 M
CSCI annual total liabilities is $2.71 million

Annual Total Assets

$23.70 M
CSCI annual total assets is $23.70 million

Annual Current Assets

$36.37 M
CSCI annual total current assets is $36.37 million

Quarterly Accounts Payable

$2.40 M
-$1.19 M-33.17%

September 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

CSCI Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.7%
CSCI quarterly accounts payable is higher than 37.7% of companies in Healthcare sector

High & Low

All-time High

$3.58 M
CSCI quarterly accounts payable is currently -33.17% below its historical high of $3.58 million

3-Year Low

$2.40 M
CSCI quarterly accounts payable is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CSCI previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
CSCI next earnings announcement has not yet been scheduled

OtherCSCIbalance sheetmetrics:

Quarterly Accounts Receivable

$1.89 M
CSCI quarterly accounts receivable is $1.89 million

Quarterly Total Liabilities

$23.75 M
CSCI quarterly total liabilities is $23.75 million

Quarterly Total Assets

$43.77 M
CSCI quarterly total assets is $43.77 million

Quarterly Current Assets

$28.22 M
CSCI quarterly total current assets is $28.22 million

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

CSCI Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-8.4%0.0%
3 y3 years+57.2%0.0%
5 y5 years+45.5%0.0%

CSCI Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-8.4%+99.8%-33.2%at low
5 y5-year-8.4%+99.8%-33.2%at low
alltimeall time-95.5%+256.2%-33.2%+931.9%

COSCIENS Biopharma Accounts Payable History

DateAnnualQuarterly
Sep 2024
-
$2.40 M(-33.2%)
Jun 2024
-
$3.58 M(+468.3%)
Dec 2023
$1.87 M(-8.4%)
-
Dec 2022
$2.04 M(+118.2%)
-
Dec 2021
$934.00 K(-21.3%)
-
Dec 2020
$1.19 M(+9.2%)
-
Dec 2019
$1.09 M(-15.2%)
-
Dec 2018
$1.28 M(+4.9%)
-
Jun 2018
-
$630.80 K(-57.2%)
Dec 2017
$1.22 M(-40.2%)
-
Dec 2016
$2.04 M(-17.8%)
-
Jun 2016
-
$1.47 M(+0.6%)
Mar 2016
-
$1.46 M(+1.3%)
Dec 2015
$2.49 M(-21.1%)
$1.45 M(+14.5%)
Sep 2015
-
$1.26 M(+29.6%)
Jun 2015
-
$973.80 K(+4.9%)
Mar 2015
-
$928.30 K(-39.8%)
Dec 2014
$3.15 M(-34.3%)
$1.54 M(+30.9%)
Sep 2014
-
$1.18 M(-29.5%)
Jun 2014
-
$1.67 M(+47.0%)
Mar 2014
-
$1.14 M(+21.8%)
Dec 2013
$4.80 M(-28.0%)
$933.90 K(-9.4%)
Sep 2013
-
$1.03 M(+105.9%)
Jun 2013
-
$500.60 K(-26.5%)
Mar 2013
-
$680.70 K(+17.1%)
Dec 2012
$6.67 M(-17.3%)
$581.20 K(-20.3%)
Sep 2012
-
$729.40 K(+56.6%)
Jun 2012
-
$465.90 K(-29.7%)
Dec 2011
$8.06 M(+26.2%)
$662.40 K(+11.6%)
Dec 2010
$6.39 M(-21.6%)
-
Dec 2009
$8.15 M(-20.5%)
-
Dec 2008
$10.26 M(-36.2%)
-
Sep 2008
-
$593.40 K(+25.6%)
Jun 2008
-
$472.60 K(-27.0%)
Mar 2008
-
$647.70 K(+29.7%)
Dec 2007
$16.08 M(+129.1%)
$499.30 K(+22.6%)
Sep 2007
-
$407.40 K(-51.2%)
Jun 2007
-
$834.20 K(+46.3%)
Mar 2007
-
$570.10 K(+98.0%)
Dec 2006
$7.02 M
$287.90 K(+24.0%)
DateAnnualQuarterly
Sep 2006
-
$232.20 K(-61.6%)
Jun 2006
-
$604.80 K(+49.1%)
Mar 2006
-
$405.50 K(+65.3%)
Dec 2005
$4.00 M(-90.4%)
$245.30 K(-30.2%)
Sep 2005
-
$351.30 K(-37.7%)
Jun 2005
-
$563.60 K(-18.8%)
Mar 2005
-
$694.00 K(+17.0%)
Dec 2004
$41.80 M(+2.1%)
$593.30 K(+34.0%)
Sep 2004
-
$442.90 K(-11.2%)
Jun 2004
-
$498.60 K(+53.3%)
Mar 2004
-
$325.30 K(-2.7%)
Dec 2003
$40.92 M(+51.4%)
$334.40 K(+1.0%)
Sep 2003
-
$331.20 K(-6.0%)
Jun 2003
-
$352.40 K(-16.5%)
Mar 2003
-
$422.00 K(+46.4%)
Dec 2002
$27.03 M(+83.7%)
$288.20 K(-27.1%)
Sep 2002
-
$395.40 K(-25.4%)
Jun 2002
-
$530.00 K(+18.9%)
Mar 2002
-
$445.70 K(+36.0%)
Dec 2001
$14.72 M(+276.6%)
$327.80 K(-9.6%)
Sep 2001
-
$362.80 K(-25.9%)
Jun 2001
-
$489.70 K(-52.4%)
Mar 2001
-
$1.03 M(-12.0%)
Dec 2000
$3.91 M(+646.0%)
$1.17 M(+6.0%)
Sep 2000
-
$1.10 M(+2.1%)
Jun 2000
-
$1.08 M(-7.7%)
Mar 2000
-
$1.17 M(+5.9%)
Dec 1999
$523.90 K(-77.0%)
$1.10 M(+8.2%)
Sep 1999
-
$1.02 M(+0.4%)
Jun 1999
-
$1.02 M(+2.4%)
Mar 1999
-
$994.00 K(+17.6%)
Dec 1998
$2.27 M(+103.4%)
$844.90 K(-0.8%)
Sep 1998
-
$851.60 K(-50.0%)
Jun 1998
-
$1.70 M(+0.7%)
Mar 1998
-
$1.69 M(+5.2%)
Dec 1997
$1.12 M(+39.3%)
$1.61 M(-32.7%)
Sep 1997
-
$2.39 M(+49.9%)
Jun 1997
-
$1.59 M(+69.1%)
Mar 1997
-
$942.10 K
Dec 1996
$802.70 K
-

FAQ

  • What is COSCIENS Biopharma annual accounts payable?
  • What is the all time high annual accounts payable for COSCIENS Biopharma?
  • What is COSCIENS Biopharma annual accounts payable year-on-year change?
  • What is COSCIENS Biopharma quarterly accounts payable?
  • What is the all time high quarterly accounts payable for COSCIENS Biopharma?
  • What is COSCIENS Biopharma quarterly accounts payable year-on-year change?

What is COSCIENS Biopharma annual accounts payable?

The current annual accounts payable of CSCI is $1.87 M

What is the all time high annual accounts payable for COSCIENS Biopharma?

COSCIENS Biopharma all-time high annual accounts payable is $41.80 M

What is COSCIENS Biopharma annual accounts payable year-on-year change?

Over the past year, CSCI annual accounts payable has changed by -$172.00 K (-8.44%)

What is COSCIENS Biopharma quarterly accounts payable?

The current quarterly accounts payable of CSCI is $2.40 M

What is the all time high quarterly accounts payable for COSCIENS Biopharma?

COSCIENS Biopharma all-time high quarterly accounts payable is $3.58 M

What is COSCIENS Biopharma quarterly accounts payable year-on-year change?

Over the past year, CSCI quarterly accounts payable has changed by $0.00 (0.00%)